Royal Bank of Canada
BBP icon

Royal Bank of Canada’s Virtus Biotech ETF BBP Stock Holding History

Royal Bank of Canada’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.35M Sell
97,170
-4,265
-4% -$371K ﹤0.01% 2138
2026
Q1 		$8.43M Buy
101,435
+12,142
+14% +$998K ﹤0.01% 2032
2025
Q4 		$7.14M Buy
+89,293
New +$6.78M ﹤0.01% 2177
2025
Q3 		– Sell
-571
Closed -$33K – 7126
2025
Q2 		$33K Sell
571
-8,120
-93% -$459K ﹤0.01% 6084
2025
Q1 		$509K Sell
8,691
-8,400
-49% -$515K ﹤0.01% 3994
2024
Q4 		$1.03M Buy
17,091
+2,800
+20% +$177K ﹤0.01% 3524
2024
Q3 		$898K Sell
14,291
-20
-0.1% -$1.25K ﹤0.01% 3653
2024
Q2 		$841K Sell
14,311
-330
-2% -$18.4K ﹤0.01% 3600
2024
Q1 		$829K Sell
14,641
-300
-2% -$17.5K ﹤0.01% 3607
2023
Q4 		$868K Sell
14,941
-122
-0.8% -$6.17K ﹤0.01% 3772
2023
Q3 		$754K Sell
15,063
-377
-2% -$19.9K ﹤0.01% 3688
2023
Q2 		$812K Sell
15,440
-182
-1% -$9.55K ﹤0.01% 3553
2023
Q1 		$770K Sell
15,622
-669
-4% -$33.6K ﹤0.01% 3531
2022
Q4 		$803K Sell
16,291
-650
-4% -$31.1K ﹤0.01% 3677
2022
Q3 		$768K Sell
16,941
-28,315
-63% -$1.31M ﹤0.01% 3667
2022
Q2 		$1.87M Sell
45,256
-19,265
-30% -$765K ﹤0.01% 2959
2022
Q1 		$2.81M Sell
64,521
-9,864
-13% -$424K ﹤0.01% 2750
2021
Q4 		$3.63M Sell
74,385
-3,517
-5% -$175K ﹤0.01% 2623
2021
Q3 		$3.96M Sell
77,902
-515
-0.7% -$26.6K ﹤0.01% 2489
2021
Q2 		$4.18M Sell
78,417
-35,702
-31% -$1.88M ﹤0.01% 2438
2021
Q1 		$5.97M Buy
114,119
+3,228
+3% +$180K ﹤0.01% 2114
2020
Q4 		$5.9M Sell
110,891
-5,206
-4% -$267K ﹤0.01% 2078
2020
Q3 		$5.54M Buy
116,097
+416
+0.4% +$19.4K ﹤0.01% 1940
2020
Q2 		$5.49M Sell
115,681
-12,724
-10% -$568K ﹤0.01% 1876
2020
Q1 		$4.81M Buy
128,405
+18,357
+17% +$759K ﹤0.01% 1832
2019
Q4 		$4.79M Sell
110,048
-26,720
-20% -$1.07M ﹤0.01% 2180
2019
Q3 		$4.91M Buy
136,768
+8,070
+6% +$309K ﹤0.01% 2104
2019
Q2 		$5.28M Buy
128,698
+18,800
+17% +$774K ﹤0.01% 2027
2019
Q1 		$4.92M Buy
109,898
+26,365
+32% +$1.1M ﹤0.01% 2020
2018
Q4 		$2.92M Sell
83,533
-24,646
-23% -$938K ﹤0.01% 2371
2018
Q3 		$4.91M Buy
108,179
+4,252
+4% +$190K ﹤0.01% 2137
2018
Q2 		$4.56M Buy
103,927
+5,218
+5% +$221K ﹤0.01% 2071
2018
Q1 		$4.07M Sell
98,709
-28,010
-22% -$1.18M ﹤0.01% 2154
2017
Q4 		$5.14M Buy
126,719
+12,944
+11% +$517K ﹤0.01% 2035
2017
Q3 		$4.73M Sell
113,775
-2,633
-2% -$105K ﹤0.01% 2030
2017
Q2 		$4.62M Buy
116,408
+21,761
+23% +$813K ﹤0.01% 2000
2017
Q1 		$3.57M Buy
94,647
+3,187
+3% +$117K ﹤0.01% 2143
2016
Q4 		$3M Buy
91,460
+48,325
+112% +$1.58M ﹤0.01% 2285
2016
Q3 		$1.44M Buy
43,135
+3,199
+8% +$98.8K ﹤0.01% 2807
2016
Q2 		$1.08M Buy
39,936
+34,600
+648% +$913K ﹤0.01% 3051
2016
Q1 		$131K Sell
5,336
-2,190
-29% -$53.3K ﹤0.01% 4623
2015
Q4 		$232K Buy
7,526
+5,226
+227% +$158K ﹤0.01% 4412
2015
Q3 		$63K Buy
2,300
+300
+15% +$10.1K ﹤0.01% 5022
2015
Q2 		$70K Hold
2,000
– – ﹤0.01% 5035
2015
Q1 		$62K Buy
+2,000
New +$58.6K ﹤0.01% 4867

Other funds holding BBP

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Royal Bank of Canada's BBP Position: Q2 2026 in Review

Royal Bank of Canada reduced its Virtus Biotech ETF (BBP) stake by 4.2% in Q2 2026, selling an estimated $371K and leaving 97,170 shares worth $9.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2138.

Royal Bank of Canada first reported a position in BBP in Q1 2015 and has held it in 45 quarters since. 26 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Royal Bank of Canada held 97,170 shares of Virtus Biotech ETF worth $9.35M as of Q2 2026.
  • Royal Bank of Canada sold 4,265 Virtus Biotech ETF shares in Q2 2026, an estimated $371K.
  • Virtus Biotech ETF made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #2138 holding.
  • Royal Bank of Canada first reported a position in Virtus Biotech ETF in Q1 2015 and has held it in 45 quarters since.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.